Demonstrates diagnostic effectiveness of PRAME and BRAF V600E in melanoma, suggesting a simpler diagnostic workflow.
Dedifferentiated melanoma can lose conventional melanocytic markers and mimic soft tissue sarcoma, complicating diagnosis. In some cases, next-generation sequencing (NGS) has been required to secure the diagnosis. We report a giant (>10 cm) sarcomatoid melanoma in which diffuse PRAME immunohistochemistry raised suspicion and concordant BRAF V600E positivity in both the sarcomatoid tumor and an associated nevus established the diagnosis of melanoma. This two-step, widely accessible workflow, PRAME screening followed by targeted BRAF V600E testing, enabled diagnosis without comprehensive NGS and may aid similarly challenging sarcomatoid cutaneous tumors.
No takes yet. Share an insight, caveat, or question.
Usui et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: